Stock Taper 
VESTAL POINT CAPITAL, LP
Latest 13F filing data - Q2 2026
Holdings
(Top positions)| STOCK | TICKER | SHARES HELD▲ ▼ | VALUE▲ ▼ |
|---|---|---|---|
 First Tracks Biotherapeutics Inc | TRAX | 1.01M | $20.38M |
 Nektar Therapeutics | NKTR | 1M | $69.81M |
 uniQure N.V. | QURE | 935K | $43.07M |
 Globus Medical, Inc. | GMED | 850K | $67.16M |
 Nyxoah S.A. | NYXH | 843.46K | $1.43M |
 Bristol-Myers Squibb Company | BMY | 800K | $46.1M |
 Rapport Therapeutics, Inc. Common Stock | RAPP | 730K | $30.42M |
 Xenon Pharmaceuticals Inc. | XENE | 700K | $42.25M |
 Viking Therapeutics, Inc. | VKTX | 680K | $26.53M |
 Insulet Corp. | PODD | 670K | $102.01M |
 Kailera Therapeutics, Inc. | KLRA | 575K | $12.67M |
 Alcon Inc. | ALC | 500K | $33.55M |
 Revolution Medicines, Inc. | RVMD | 450K | $84.28M |
 AstraZeneca PLC | AZN | 450K | $85.33M |
 GE HealthCare Technologies Inc. | GEHC | 450K | $28.8M |
 United Therapeutics Corporation | UTHR | 435K | $235.7M |
 Tectonic Therapeutic, Inc. | TECX | 425K | $14.61M |
 Olema Pharmaceuticals, Inc. | OLMA | 418.55K | $5.24M |
 Repligen Corporation | RGEN | 400K | $54.58M |
 Ascendis Pharma A/S | ASND | 375K | $100.02M |